Tough UK line on rare-disease drugs stirs concern after Brexit
Bloomberg A tougher stance in the UK on funding expensive medicines for rare diseases is raising questions about the government’s pledges to support a life-sciences industry that’s already rattled by Brexit. A proposal to introduce a cap on coverage of treatments within the state-run health system would have a significant impact on access to ultra-rare disease drugs, said Heidi ...
Read More »